CRF–CRF 1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats

Is there a common molecular pathway for addiction?

Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388

Incubation of cocaine craving after withdrawal

Grimm, J. W., Hope, B. T., Wise, R. A., & Shaham, Y. (2001) · Nature · doi:10.1038/35084134 · Cited by 1,031

Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction

Koob, G. F., & Le Moal, M. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1442 · Cited by 963

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress

Bale, T. L., Contarino, A., Smith, G. W., Chan, R. K. W., Gold, L. H., Sawchenko, P. E., Koob, G. F., Vale, W. W., & Lee, K. (2000) · Nature Genetics · doi:10.1038/74263 · Cited by 850

Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas

Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002) · Neuron · doi:10.1016/s0896-6273(02)00625-6 · Cited by 701

Dramatic decreases in brain reward function during nicotine withdrawal

Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis

Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565

Daily intake of nicotine during cigarette smoking

Benowitz, N. L., & Jacob, P. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.67 · Cited by 502

Role of Corticotropin-Releasing Factor in Drug Addiction

Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 474

Incubation of cocaine craving after withdrawal: a review of preclinical data

Lü, L., Grimm, J. W., Hope, B. T., & Shaham, Y. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.027 · Cited by 443

Predator odor stress alters corticotropin-releasing factor-1 receptor (CRF1R)-dependent behaviors in rats

Roltsch, E. A., Baynes, B. B., Mayeux, J. P., Whitaker, A. M., Baiamonte, B. A., & Gilpin, N. W. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.005 · Cited by 41

Behavioral effects of nicotine withdrawal in adult male and female rats

Hamilton, K. R., Berger, S. S., Perry, M. E., & Grunberg, N. E. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.10.010 · Cited by 40

Neuropharmacology of the Interoceptive Stimulus Properties of Nicotine

Wooters, T. E., Bevins, R. A., & Bardo, M. T. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902030243 · Cited by 42

Electron microscopic localization of corticotropin‐releasing factor (CRF) and CRF receptor in rat and mouse central nucleus of the amygdala

Treweek, J. B., Jaferi, A., Colago, E. E. O., Zhou, P., & Pickel, V. M. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21884 · Cited by 38

Increased startle potentiation to unpredictable stressors in alcohol dependence: Possible stress neuroadaptation in humans.

Moberg, C. A., Bradford, D. E., Kaye, J. T., & Curtin, J. J. (2017) · Journal of Abnormal Psychology · doi:10.1037/abn0000265 · Cited by 37

Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats

Qi, X., Guzhva, L., Yang, Z., Febo, M., Shan, Z. J., Wang, K., & Bruijnzeel, A. W. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.07.007 · Cited by 39

Development of Novel Pharmacotherapeutics for Tobacco Dependence: Progress and Future Directions

Harmey, D., Griffin, P. R., & Kenny, P. J. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts201 · Cited by 37

A neuronal coping mechanism linking stress-induced anxiety to motivation for reward

Klenowski, P. M., Zhao-Shea, R., Freels, T. G., Molas, S., Zinter, M., M'angale, P. G., Xiao, C., Martínez‐Núñez, L., Thomson, T., & Tapper, A. R. (2023) · Science Advances · doi:10.1126/sciadv.adh9620 · Cited by 38

β2* nAChRs on VTA dopamine and GABA neurons separately mediate nicotine aversion and reward

Grieder, T. E., Besson, M., Maal‐Bared, G., Pons, S., Maskos, U., & van der Kooy, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908724116 · Cited by 45

Neuropeptide systems and new treatments for nicotine addiction

Bruijnzeel, A. W. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4513-5 · Cited by 36

Nicotine Self-Administration Induces CB1-Dependent LTP in the Bed Nucleus of the Stria Terminalis

Reisiger, A.-R., Kaufling, J., Manzoni, O. J., Cador, M., Georges, F. E., & Caillé, S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3149-13.2014 · Cited by 37

Extended access nicotine self-administration with periodic deprivation increases immature neurons in the hippocampus

Cohen, A., Soleiman, M. T., Talia, R., Koob, G. F., George, O., & Mandyam, C. D. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3685-0 · Cited by 35

Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Signaling and the Dark Side of Addiction

Miles, O. W., May, V., & Hammack, S. E. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1147-6 · Cited by 34

Effect of early life social adversity on drug abuse vulnerability: Focus on corticotropin-releasing factor and oxytocin

Bardo, M. T., Hammerslag, L. R., & Malone, S. G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108567 · Cited by 32

Assessment of nicotine withdrawal-induced changes in sucrose preference in mice

Alkhlaif, Y., Bağdaş, D., Jackson, A. B., Park, A. J., & Damaj, M. I. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.08.013 · Cited by 33

Parvalbumin Interneurons of Central Amygdala Regulate the Negative Affective States and the Expression of Corticotrophin-Releasing Hormone During Morphine Withdrawal

Wang, L., Shen, M., Jiang, C., Ma, L., & Wang, F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw060 · Cited by 29

Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse

Schmidt, H. D., Rupprecht, L. E., & Addy, N. (2018) · Complex Psychiatry · doi:10.1159/000494799 · Cited by 33

Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats

Kamdi, S. P., Nakhate, K. T., Dandekar, M. P., Kokare, D. M., & Subhedar, N. K. (2009) · Appetite · doi:10.1016/j.appet.2009.07.017 · Cited by 31

Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction

Cross, A. J., Anthenelli, R. M., & Li, X. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.021 · Cited by 31

Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence

Kaye, J. T., Bradford, D. E., Magruder, K. P., & Curtin, J. J. (2017) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.353 · Cited by 29

An enzymatic approach reverses nicotine dependence, decreases compulsive-like intake, and prevents relapse

Kallupi, M., Xue, S., Zhou, B., Janda, K. D., & George, O. (2018) · Science Advances · doi:10.1126/sciadv.aat4751 · Cited by 30

Vulnerability to nicotine abstinence-related social anxiety-like behavior: Molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor

Aydın, Ç., Oztan, O., & Isgor, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.12.056 · Cited by 30

Chronic nicotine pretreatment is sufficient to upregulate α4* nicotinic receptors and increase oral nicotine self-administration in mice

Renda, A., & Nashmi, R. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-89 · Cited by 33

A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration

Cippitelli, A., Schoch, J., Debevec, G., Brunori, G., Zaveri, N. T., & Toll, L. (2016) · Scientific Reports · doi:10.1038/srep26594 · Cited by 29

Hypocretin mechanisms in nicotine addiction: evidence and speculation

Corrigall, W. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1588-2 · Cited by 29

Converging vulnerability factors for compulsive food and drug use

Serafine, K. M., O’Dell, L. E., & Zorrilla, E. P. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108556 · Cited by 29

Reinforcement principles for addiction medicine; from recreational drug use to psychiatric disorder

Edwards, S. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.005 · Cited by 28

Selective CRF2 receptor agonists ameliorate the anxiety- and depression-like state developed during chronic nicotine treatment and consequent acute withdrawal in mice

Bagosi, Z., Palotai, M., Simon, B., Bokor, P., Búzás, A., Balangó, B., Pintér, D., Jászberényi, M., Csabafi, K., & Szabó, G. (2016) · Brain Research · doi:10.1016/j.brainres.2016.09.044 · Cited by 28

Neuropeptide modulation of addiction: Focus on galanin

Genders, S. G., Scheller, K. J., & Djouma, E. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.06.021 · Cited by 30

Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype

Aydın, Ç., Oztan, O., & Isgor, C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.067 · Cited by 27

Increased expression of CRF and CRF-receptors in dorsal striatum, hippocampus, and prefrontal cortex after the development of nicotine sensitization in rats

Carboni, L., Romoli, B., Bate, S. T., Romualdi, P., & Zoli, M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.027 · Cited by 25

Reward, Motivation, and Addiction

Koob, G. F., Everitt, B. J., & Robbins, T. W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385870-2.00041-x · Cited by 25

Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal

Qi, X., Shan, Z. J., Ji, Y., Guerra, V., Alexander, J. C., Ormerod, B. K., & Bruijnzeel, A. W. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.25 · Cited by 24

Linking drug and food addiction: an overview of the shared neural circuits and behavioral phenotype

Passeri, A., Municchi, D., Cavalieri, G., Babicola, L., Ventura, R., & Segni, M. D. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1240748 · Cited by 32

Hormones in the Mentally Disturbed Brain: Steroids and Peptides in the Development and Treatment of Psychopathology

Taylor, G. T., Maloney, S. E., Dearborn, J. T., & Weiss, J. (2009) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152409789630398 · Cited by 23

Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice

Tobey, K. M., Walentiny, D. M., Wiley, J. L., Carroll, F. I., Damaj, M. I., Azar, M. R., Koob, G. F., George, O., Harris, L. S., & Vann, R. E. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2703-3 · Cited by 23

Stress induces behavioral sensitization, increases nicotine-seeking behavior and leads to a decrease of CREB in the nucleus accumbens

Leão, R. M., Cruz, F. C., Marin, M. T., & Planeta, C. S. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.01.025 · Cited by 23

Stress and nicotine during adolescence disrupts adult hippocampal‐dependent learning and alters stress reactivity

Holliday, E. D., Logue, S. F., Oliver, C. F., Bangasser, D. A., & Gould, T. J. (2019) · Addiction Biology · doi:10.1111/adb.12769 · Cited by 23

Role of corticotropin-releasing factor in alcohol and nicotine addiction

Simpson, S., Shankar, K., Kimbrough, A., & George, O. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146850 · Cited by 24

Multidimensional Intersection of Nicotine, Gene Expression, and Behavior

Sherafat, Y., Bautista, M. R., & Fowler, C. D. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.649129 · Cited by 25

Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future

Cannella, N., Ubaldi, M., Masi, A., Bramucci, M., Roberto, M., Bifone, A., & Ciccocioppo, R. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.014 · Cited by 24

Chapter 1 Recent Advances in Corticotropin-Releasing Factor Receptor Antagonists

Dzierba, C. D., Hartz, R. A., & Bronson, J. J. (2008) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)00001-8 · Cited by 22

The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice

Valero, E., Gómez-Milanés, I., Almela, P., Couto, B. R. D., Laorden, M. L., Milanés, M. V., & Núñez, C. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.018 · Cited by 22

Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal

Pintér-Kübler, B., Ferenczi, S., Núñez, C., Zelei, E., Polyák, Á., Milanés, M. V., & Kovács, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067027 · Cited by 20

Corticotropin releasing factor and drug seeking in substance use disorders: Preclinical evidence and translational limitations

Mantsch, J. R. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100038 · Cited by 22

Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide Plays Critical Role in Psychostimulant-Induced Depression

Qing, M., Kim, H., Oh, S., Lee, Y., Hu, Z., & Oh, K. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.141 · Cited by 20

Increases in compulsivity, inflammation, and neural injury in HIV transgenic rats with escalated methamphetamine self-administration under extended-access conditions

de Guglielmo, G., Fu, Y., Chen, J., Larrosa, E., Hoang, I. B., Kawamura, T., Lorrai, I., Zorman, B., Bryant, J., George, O., et al. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146502 · Cited by 18

Nicotine Addiction: Mechanisms and Consequences

Rosenthal, D. G., Weitzman, M. L., & Benowitz, N. L. (2011) · International Journal of Mental Health · doi:10.2753/imh0020-7411400102 · Cited by 18

Biodistribution and Radiation Dosimetry of 11C-Nicotine from Whole-Body PET Imaging in Humans

Garg, P., Lokitz, S. J., Nazih, R., & Garg, S. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.180059 · Cited by 16

Influence of neuropathic pain on nicotinic acetylcholine receptor plasticity and behavioral responses to nicotine in rats

Brunori, G., Schoch, J., Mercatelli, D., Ozawa, A., Toll, L., & Cippitelli, A. (2018) · Pain · doi:10.1097/j.pain.0000000000001318 · Cited by 17

Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats

Qi, X., Guzhva, L., Ji, Y. R., & Bruijnzeel, A. W. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.06.031 · Cited by 16

Altered mRNA Levels of Stress-Related Peptides in Mouse Hippocampus and Caudate-Putamen in Withdrawal after Long-Term Intermittent Exposure to Tobacco Smoke or Electronic Cigarette Vapour

Carboni, L., Ponzoni, L., Braida, D., Sala, M., Gotti, C., & Zoli, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020599 · Cited by 15

Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice

Mattioli, L., & Perfumi, M. C. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109348166 · Cited by 15

Effects of stressors on the reinforcing efficacy of nicotine in adolescent and adult rats

Zou, S., Funk, D. R., Shram, M. J., & Lê, A. D. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3314-3 · Cited by 15

Molecular, Neuronal, and Behavioral Effects of Ethanol and Nicotine Interactions

Klenowski, P. M., & Tapper, A. R. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2017_89 · Cited by 15

Synthesis of substituted pyrimidines as corticotropin releasing factor (CRF) receptor ligands

Kuppast, B., Spyridaki, K., Liapakis, G., & Fahmy, H. T. Y. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.040 · Cited by 15

Anthocyanins in Lycium ruthenicum Murray reduce nicotine withdrawal-induced anxiety and craving in mice

Luo, J., Bian, L.-H., Yao, Z., Wang, X., Li, Q., Guo, J., & Shi, J. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136152 · Cited by 15

Overview of Nicotine Withdrawal and Negative Reinforcement (Preclinical)

George, O., & Koob, G. F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00001-6 · Cited by 15

The role of pituitary adenylyl cyclase activating polypeptide in affective signs of nicotine withdrawal

Nega, S., Marquez, P. V., Hamid, A., Ahmad, S. M., & Lutfy, K. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24649 · Cited by 14

Activation of trace amine‐associated receptor 1 attenuates nicotine withdrawal‐related effects

Wu, R., Liu, J., Johnson, B., Huang, Y., Zhang, Y., & Li, J. (2021) · Addiction Biology · doi:10.1111/adb.13075 · Cited by 14

Insulin dependent and independent normalization of blood glucose levels reduces the enhanced rewarding effects of nicotine in a rodent model of diabetes

Íbias, J., O’Dell, L. E., & Nazarian, A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.018 · Cited by 14

The Limbic System in Co-Occurring Substance Use and Anxiety Disorders: A Narrative Review Using the RDoC Framework

Lin, E. R.-H., Veenker, F., Manza, P., Yonga, M.-V., Abey, S. K., Wang, G., & Volkow, N. D. (2024) · Brain Sciences · doi:10.3390/brainsci14121285 · Cited by 15

Neuropeptides in Psychiatry

Suchak, V., Sathyanath, S., & Kakunje, A. (2022) · Archives of Medicine and Health Sciences · doi:10.4103/amhs.amhs_91_22 · Cited by 12

Long-term effects of juvenile nicotine exposure on abstinence-related social anxiety-like behavior and amygdalar cannabinoid receptor 1 (CB1R) mRNA expression in the novelty-seeking phenotype

Aydın, Ç., Oztan, O., & Isgor, C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.11.015 · Cited by 13

A neurobiological basis for nicotine withdrawal

Grunberg, N. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708964104 · Cited by 13

SU-6656, a Selective Src Kinase Inhibitor, Attenuates Mecamylamine-Precipitated Nicotine Withdrawal Syndrome in Mice

Rehni, A. K., Singh, T. G., & Arora, S. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr228 · Cited by 13

The dark side of compulsive eating and food addiction

Zorrilla, E. P., & Koob, G. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816207-1.00006-8 · Cited by 14

Sex differences in nicotine intake and relapse behavior in nicotine-dependent adult wistar rats

Chellian, R., Behnood‐Rod, A., & Bruijnzeel, A. W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1415219 · Cited by 11

Amplified reacquisition of nicotine self-administration in rats by repeated stress during abstinence

Yu, G., Chen, H., & Sharp, B. M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3501-x · Cited by 12

Enhanced nicotine-seeking behavior following pre-exposure to repeated cocaine is accompanied by changes in BDNF in the nucleus accumbens of rats

Leão, R. M., Cruz, F. C., de Oliveira, P. E. C., Rossetto, D. D. B., Valentini, S. R., Zanelli, C. F., & Planeta, C. S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.007 · Cited by 13

Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats

Goeders, N. E., Cohen, A., Fox, B. S., Azar, M. R., George, O., & Koob, G. F. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2682-4 · Cited by 12

Acute nicotine abstinence amplifies subjective withdrawal symptoms and threat-evoked fear and anxiety, but not extended amygdala reactivity

Kim, H. C., Kaplan, C. M., Islam, S., Anderson, A. S., Piper, M. E., Bradford, D. E., Curtin, J. J., DeYoung, K. A., Smith, J. F., Fox, A. S., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288544 · Cited by 9

Translational research in addiction: Toward a framework for the development of novel therapeutics

Paterson, N. E. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.017 · Cited by 12

Emerging targets for addiction neuropharmacology

Ubaldi, M., Cannella, N., & Ciccocioppo, R. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.018 · Cited by 11

Tamoxifen and mifepriston modulate nicotine induced conditioned place preference in female rats

Yararbaş, G., & Pöğün, Ş. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.01.013 · Cited by 12

Changes in striatal dopamine release and locomotor activity following acute withdrawal from chronic nicotine are mediated by CRF1, but not CRF2, receptors

Búzás, A., Bokor, P., Balangó, B., Pintér, D., Palotai, M., Simon, B., Csabafi, K., Telegdy, G., Szabó, G., & Bagosi, Z. (2018) · Brain Research · doi:10.1016/j.brainres.2018.10.028 · Cited by 11

Neurobiology of Stress-Induced Nicotine Relapse

Wang, X., Chen, Y., Dong, J., Ge, J., Liu, X., & Liu, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031482 · Cited by 10

More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder

Moerke, M. J., McMahon, L. R., & Wilkerson, J. L. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018028 · Cited by 11

Animal Models of Drug Dependence: Motivational Perspective

Koob, G. F. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_15 · Cited by 10

Synthesis of New Thiazolo[4,5-d]pyrimidines as Corticotropin Releasing Factor Modulators

Kuppast, B., Spyridaki, K., Lynch, C., Hu, Y., Liapakis, G., Davies, G. E., & Fahmy, H. T. Y. (2014) · Medicinal Chemistry · doi:10.2174/1573406410666140724115627 · Cited by 9

Drug addiction co-morbidity with alcohol: Neurobiological insights

McGinn, M. A., Pantazis, C. B., Tunstall, B. J., Marchette, R. C. N., Carlson, E. R., Said, N., Koob, G. F., & Vendruscolo, L. F. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.11.002 · Cited by 11

Administration of BDNF in the ventral tegmental area produces a switch from a nicotine‐non‐dependent D1R‐mediated motivational state to a nicotine‐dependent‐like D2R‐mediated motivational state

Grieder, T. E., Yee, M., Vargas-Pérez, H., Maal‐Bared, G., George, S. R., Ting‐A‐Kee, R. A., George, O., & van der Kooy, D. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15579 · Cited by 10

Alcohol Use Disorder: Stress, Negative Reinforcement, and Negative Urgency

Vendruscolo, L. F., Koob, G. F., & Zorrilla, E. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-32483-3_36 · Cited by 8

Altered neuronal activity in the ventromedial prefrontal cortex drives nicotine intake escalation

Abarkan, M., Fois, G. R., Vouillac‐Mendoza, C., Ahmed, S. H., & Guillem, K. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01428-9 · Cited by 5

Progressive and Lasting Amplification of Accumbal Nicotine-Seeking Neural Signals

Guillem, K., & Peoples, L. L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2820-09.2010 · Cited by 8

Chronic Nicotine Consumption and Withdrawal Regulate Melanocortin Receptor, CRF, and CRF Receptor mRNA Levels in the Rat Brain

Gözen, O., Aypar, B., Bintepe, M. O., Gürkan, F. T., Balkan, B., Koylu, E. O., Kanıt, L., & Keser, A. (2024) · Brain Sciences · doi:10.3390/brainsci14010063 · Cited by 7

Tobacco addiction

Addicott, M. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815298-0.00009-5 · Cited by 6

Emerging therapeutic targets for the treatment of nicotine addiction

Kenny, P. J. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.6 · Cited by 6

The influence of stress and social defeat on neurobiological reinforcement mechanisms across reward to withdrawal in nicotine addiction

Shankar, K., Bonnet-Zahedi, S., & George, O. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06852-5 · Cited by 6

Acupuncture on the Stress‐Related Drug Relapse to Seeking

Roh, H. S., Park, B. R., Jang, E. Y., Kim, J. S., & Gwak, Y. S. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/5367864 · Cited by 6

Targeting the Brain Stress Systems for the Treatment of Tobacco/Nicotine Dependence: Translating Preclinical and Clinical Findings

Verplaetse, T. L., & McKee, S. A. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0115-x · Cited by 5

Epigallocatechin Gallate Ameliorates Nicotine Withdrawal Conditions-Induced Somatic and Affective Behavior Changes in Mice and Its Molecular Mechanism

Rahmadi, M., Nurhan, A. D., Rahmawati, R. I. A., Damayanti, T. F., Purwanto, D. A., & Khotib, J. (2023) · Behavioural Neurology · doi:10.1155/2023/5581893 · Cited by 4

Clinical Syndromes of Substance Use Disorder

Addy, N., & Solecki, W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00038-x · Cited by 4

L-theanine attenuates nicotine reward and withdrawal signs in mice

Alkhlaif, Y., El-Halawany, M. S., Toma, W. B., Park, A. J., Hamouda, A. K., & Damaj, M. I. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137279 · Cited by 4

Microstructural meal pattern analysis reveals a paradoxical acute increase in food intake after nicotine despite its long-term anorexigenic effects

Shankar, K., Ambroggi, F., & George, O. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06071-2 · Cited by 6

Ro 32-0432 attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice

Singh, T. G., Rehni, A. K., & Arora, S. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0825-0 · Cited by 4

Drug Addiction: A Critical Problem Calling for Novel Solutions

Tyndale, R. F. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.11 · Cited by 4

Pharmacotherapy in smoking cessation: Corticotropin Releasing Factor receptors as emerging intervention targets

Sotiriou, I., Chalkiadaki, K., Nikolaidis, C., Sidiropoulou, K., & Chatzaki, Ε. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.02.082 · Cited by 3

Blockade of corticotropin-releasing factor receptor 1 in the central amygdala prevents cocaine-seeking behaviour induced by orexin-A administered to the posterior paraventricular nucleus of the thalamus in male rats

Matzeu, A., & Martin‐Fardon, R. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200213 · Cited by 3

Teneurin C-terminal associated peptide (TCAP)-1 attenuates the development and expression of naloxone-precipitated morphine withdrawal in male Swiss Webster mice

Mueller, L. E., Wexler, R. S., Lovejoy, D. A., Stein, R. B., & Slee, A. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06582-0 · Cited by 3

Extended access to nicotine leads to a CRF1receptor dependent increase in anxiety-like behavior and hyperalgesia in rats

Cohen, A., Treweek, J. B., Edwards, S., Leão, R. M., Schulteis, G., Koob, G. F., & George, O. (2013) · Addiction Biology · doi:10.1111/adb.12077 · Cited by 73

Nicotine dependence produces hyperalgesia: Role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA)

Baiamonte, B. A., Valenza, M., Roltsch, E. A., Whitaker, A. M., Baynes, B. B., Sabino, V., & Gilpin, N. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.025 · Cited by 58

Corticotropin-Releasing Factor-1 Receptor Activation Mediates Nicotine Withdrawal-Induced Deficit in Brain Reward Function and Stress-Induced Relapse

Bruijnzeel, A. W., Prado, M., & Isaac, S. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.010 · Cited by 132

Effects of the CRF receptor antagonist d-Phe CRF(12–41) and the α2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats

Zislis, G., Desai, T. V., Prado, M., Shah, H. P., & Bruijnzeel, A. W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.09.007 · Cited by 111

Antagonism of CRF Receptors Prevents the Deficit in Brain Reward Function Associated with Precipitated Nicotine Withdrawal in Rats

Bruijnzeel, A. W., Zislis, G., Wilson, C., & Gold, M. S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301192 · Cited by 107